Question: Does four-day antithrombin therapy seem to attenuate hypercoagulability in patients suffering from sepsis?
Answer: The current study shows a distinct hypercoagulability in patients suffering from severe sepsis, which was not reversed by high-dose AT treatment over four days. This finding supports recent data showing that modulation of coagulatory activation in septic patients by AT does not occur before one week of therapy.